Explore how tumor necrosis factor inhibitors (TNFis) may reduce cardiovascular risks in patients with inflammatory arthritis, ...

Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced the first participant ...

No safety concerns emerged in part one of the phase 1 trial assessing CS014, a histone deacetylase inhibitor that has ...

Researchers used feedback from patient focus groups to develop tools and recommendations for shared anticoagulant ...

Laura Williamson American Heart Association News Flossing regularly may lower the risk of some strokes as well as a type of irregular heart rhythm that can increase stroke risk, new research suggests.

Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation.

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...

San Antonio Spurs star Victor Wembanyama is out for the remainder of the NBA season with a deep vein thrombosis in his right arm.

Omeros Corporation (Nasdaq: OMER) today announced statistical analysis results related to the expanded access program (EAP) ...

⦁ The effects of angioplasty or stenting for people with deep vein thrombosis (DVT) are unclear. ⦁ Further larger studies are needed to determine whether angioplasty and stenting are safe and ...

Solid Biosciences Inc. (SLDB) shares surged more than 31% on Tuesday, their best session since January 2024, and extended ...

Compared with thrombotic stroke, hemorrhagic stroke has more than double the odds of diagnostic delay in pregnant and postpartum patients.